Sutro Biopharma (NASDAQ:STRO – Get Free Report) was upgraded by equities research analysts at Piper ...
On Monday, Sutro Biopharma Inc (NASDAQ: STRO) was 10.20% up from the session before settling in for ...
Piper Sandler raised Sutro Biopharma from a "neutral" rating to an "overweight" rating and set a $2....
Shares of Sutro Biopharma, Inc. (NASDAQ:STRO - Get Free Report) have been assigned a consensus recom...